STRIKE - Treating Patients With Early Axial Spondyloarthritis to Target - a 1 Year Randomized Controlled Study Taking an Intense Treatment Approach Versus Routine Treatment
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 27 Nov 2017
At a glance
- Drugs Adalimumab (Primary)
- Indications Ankylosing spondylitis; Spondylarthritis
- Focus Therapeutic Use
- Acronyms STRIKE
- Sponsors AbbVie
- 05 Nov 2017 Planned End Date changed from 10 Apr 2020 to 31 Jan 2018.
- 05 Nov 2017 Planned primary completion date changed from 13 Sep 2019 to 31 Jan 2018.
- 05 Nov 2017 Status changed from recruiting to active, no longer recruiting.